FDA product code KQP: Fluorescent Proc. (Qual.), Galactose-1-Phosphate Uridyl Transferase
KQP is the FDA product code for fluorescent proc. (qual.), galactose-1-phosphate uridyl transferase. It is a Class II device, regulated under 21 CFR 862.1315 and reviewed by the Clinical Chemistry panel. FDA has cleared 7 510(k) submissions under KQP, from 4 different applicants. The average 510(k) review took 186 days (median 219). FDA has posted 1 recall for KQP devices, 1 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Fluorescent Proc. (Qual.), Galactose-1-Phosphate Uridyl Transferase |
| Device class | Class II |
| Regulation | 21 CFR 862.1315 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
Compare with all 510(k) review times · Search every KQP clearance
Top KQP applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Astoria-Pacific, Inc. | 3 | 2011-07-15 |
| Bio-Rad | 2 | 1999-11-04 |
| Perkinelmer, Inc. | 1 | 2010-06-11 |
| Alpkem Corp. | 1 | 1990-01-11 |
Most recent KQP clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K102643 | Astoria-Pacific, Inc. | SPOTCHECK NEONATAL GALT MICROPLATE REAGENT KIT | 2011-07-15 | 304 |
| K101392 | Astoria-Pacific, Inc. | NEOPAC SOFTWARE, 3007 DIGITAL PHOTOMETER/FLUOROMETER MODEL NA, 307 AND 350D | 2011-02-04 | 262 |
| K100101 | Perkinelmer, Inc. | GSP NEONATALGALT KIT, MODEL 3303-001U | 2010-06-11 | 149 |
| K993536 | Bio-Rad | BIO-RAD CODA NEONATAL GALT ASSAY | 1999-11-04 | 16 |
| K990827 | Bio-Rad | MICROPLATE NEONATAL GALT ASSAY | 1999-04-09 | 28 |
Recalls for KQP devices
1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2026-05-18.
| Year | Recalls |
|---|---|
| 2026 | 1 |
Frequently asked questions
What is FDA product code KQP?
KQP is the FDA product code for fluorescent proc. (qual.), galactose-1-phosphate uridyl transferase. It is a Class II device, regulated under 21 CFR 862.1315 and reviewed by the Clinical Chemistry panel.
What device class is KQP?
Class II, regulation 21 CFR 862.1315. Typical premarket route: 510(k).
How long does a 510(k) take for product code KQP?
Across 7 cleared submissions the average was 186 days from receipt to decision (median 219).
Which companies have the most KQP clearances?
Astoria-Pacific, Inc. (3); Bio-Rad (2); Perkinelmer, Inc. (1); Alpkem Corp. (1).
Have KQP devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2026-05-18.
Next steps
- Run an FDA pathway report with predicate devices for product code KQP
- Run a recall and safety report across every KQP manufacturer
- Watch product code KQP for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times